ACS Omega,
Год журнала:
2023,
Номер
8(8), С. 7536 - 7545
Опубликована: Фев. 20, 2023
Anticancer
peptides
(ACPs)
are
promising
antitumor
resources,
and
developing
acid-activated
ACPs
as
more
effective
selective
drugs
would
represent
new
progress
in
cancer
therapy.
In
this
study,
we
designed
a
class
of
hybrid
LK-LE
by
altering
the
charge
shielding
position
anionic
binding
partner
LE
based
on
cationic
ACP
LK
investigated
their
pH
response,
cytotoxic
activity,
serum
stability,
hoping
to
achieve
desirable
acid-activatable
ACP.
As
expected,
obtained
could
be
activated
exhibit
remarkable
activity
rapid
membrane
disruption
at
acidic
pH,
whereas
its
killing
alleviated
normal
showing
significant
response
compared
with
LK.
Importantly,
study
found
that
peptide
LK-LE3
N-terminal
displayed
notably
low
cytotoxicity
demonstrating
masking
is
extremely
important
for
improvement
toxicity
stability.
short,
our
work
opens
avenue
design
potential
targeting
agents
treatment.
Advanced Functional Materials,
Год журнала:
2023,
Номер
33(31)
Опубликована: Апрель 28, 2023
Abstract
The
development
of
colitis‐associated
colorectal
cancer
is
known
to
be
associated
with
the
inflammation‐dysplasia‐carcinoma
pathway,
and
thus,
chronic
inflammation
represents
an
inducer
promoter
cancer.
To
inhibit
evolution
from
colitis
provide
efficient
anticancer
therapy,
a
surface‐engineered
vanadium
carbide
MXene
nanoenzyme
(MXenzyme)
developed
both
amino
functionalization
gallium
doping
(Ga/V
2
C‐NH
).
Benefiting
multiple
enzyme‐mimicking
activities,
MXenzymes
have
shown
great
potential
decrease
excessive
reactive
oxygen
species
levels
proinflammatory
cytokines,
resulting
in
good
anti‐inflammatory
effects
on
dextran
sulfate
sodium‐induced
acute
colitis.
Moreover,
gallium‐doped
amino‐functionalized
surface
can
mediate
improved
MXene‐tumor
interactions
inhibitory
cell
proliferation,
achieving
precise
chemo‐photothermal
therapy.
Elemental
into
also
highlighted
as
feasible
strategy
achieve
loading
controlled
release
gallium.
As
result,
complete
tumor
ablation
without
further
recurrence
observed
for
colon
cancer‐bearing
mice
that
receive
Ga/V
near
infrared
irradiation,
while
MXenzyme
system
displays
excellent
biocompatibility
at
cellular
animal
levels.
These
findings
not
only
enrich
research
MXene,
but
illustrate
its
therapeutic
promise
anti‐inflammation
photoenhanced
antitumor
therapy
diseases.
Bioactive Materials,
Год журнала:
2023,
Номер
31, С. 206 - 230
Опубликована: Авг. 14, 2023
Traditional
cancer
therapy
methods,
especially
those
directed
against
specific
intracellular
targets
or
signaling
pathways,
are
not
powerful
enough
to
overcome
tumor
heterogeneity
and
therapeutic
resistance.
Oncolytic
peptides
that
can
induce
membrane
lysis-mediated
cell
death
subsequent
anticancer
immune
responses,
has
provided
a
new
paradigm
for
therapy.
However,
the
clinical
application
of
oncolytic
is
always
limited
by
some
factors
such
as
unsatisfactory
bio-distribution,
poor
stability,
off-target
toxicity.
To
these
limitations,
polymers
stand
out
prospective
materials
owing
their
high
chemical
versatility,
scalable
production
capacity,
which
potential
drive
revolution
in
treatment.
This
review
provides
an
overview
mechanism
structure-activity
relationship
peptides.
Then
peptides-mediated
combination
nano-delivery
strategies
summarized.
Emphatically,
current
research
progress
been
highlighted.
Lastly,
challenges
prospects
development
discussed.
The
Recalcitrance
of
pathogens
to
traditional
antibiotics
has
made
treating
and
eradicating
bacterial
infections
more
difficult.
In
this
regard,
developing
new
antimicrobial
agents
combat
antibiotic-resistant
strains
become
a
top
priority.
Antimicrobial
peptides
(AMPs),
ubiquitous
class
naturally
occurring
compounds
with
broad-spectrum
anti-pathogen
activity,
hold
significant
promise
as
one
the
most
effective
solutions
current
resistance
(AMR)
crisis.
Several
AMPs
have
been
identified
evaluated
for
their
therapeutic
application,
many
already
in
drug
development
pipeline.
Their
distinct
properties,
such
high
target
specificity,
potency,
ability
bypass
microbial
mechanisms,
make
them
promising
alternative
antibiotics.
Nonetheless,
several
challenges,
toxicity,
lability
proteolytic
degradation,
low
stability,
poor
pharmacokinetics,
production
costs,
continue
hamper
clinical
applicability.
Therefore,
much
recent
research
focused
on
optimizing
peptides'
properties
improve
performance.
By
understanding
physiochemical
AMPs,
amphipathicity,
hydrophobicity,
structural
conformation,
amino
acid
distribution,
composition,
that
correspond
researchers
can
design
desired
improved
review,
we
highlight
some
key
strategies,
rational
de
novo
design,
used
optimize
performance
AMPs.
We
also
discuss
how
evolution
predictive
computational
tools
technologies
utilize
artificial
intelligence
machine
learning
are
increasingly
being
synthesize
lead
candidates
efficacy.
Acta Pharmaceutica Sinica B,
Год журнала:
2023,
Номер
14(4), С. 1759 - 1771
Опубликована: Дек. 30, 2023
Bacterial
biofilm-associated
infection
was
one
of
the
most
serious
threats
to
human
health.
However,
effective
drugs
for
drug-resistance
bacteria
or
biofilms
remain
rarely
reported.
Here,
we
propose
an
innovative
strategy
develop
a
multifunctional
antimicrobial
agent
with
broad-spectrum
antibacterial
activity
by
coupling
photosensitizers
(PSs)
peptides
(AMPs).
This
capitalizes
on
ability
PSs
generate
reactive
oxygen
species
(ROS)
and
membrane-targeting
property
AMPs
(KRWWKWIRW,
peptide
screened
artificial
neural
network),
synergistically
enhancing
activity.
In
addition,
unlike
conventional
aggregation-caused
quenching
(ACQ)
photosensitizers,
aggregation-induced
emission
(AIE)
show
stronger
fluorescence
in
aggregated
state
help
visualize
mechanism.
vitro
experiments
demonstrated
excellent
killing
effects
developed
against
both
Gram-positive
(G+)
Gram-negative
(G–)
bacteria.
The
bacterial-aggregations
induced
enhanced
photoactivatable
G–
Notably,
it
exhibited
significant
effect
destroying
MRSA
biofilms.
Moreover,
also
showed
remarkable
efficacy
treating
wound
infections
mice
vivo.
holds
potential
addressing
challenges
posed
bacterial
drug-resistant
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Май 26, 2022
The
search
for
efficient
antimicrobial
therapies
that
can
alleviate
suffering
caused
by
infections
from
resistant
bacteria
is
more
urgent
than
ever
before.
Infections
multi-resistant
pathogens
represent
a
significant
and
increasing
burden
to
healthcare
society
researcher
are
investigating
new
classes
of
bioactive
compounds
slow
down
this
development.
Antimicrobial
peptides
the
innate
immune
system
one
promising
class
offers
potential
solution
antibiotic
resistance
problem
due
their
mode
action
on
microbial
membranes.
However,
challenges
associated
with
pharmacokinetics,
bioavailability
off-target
toxicity
slowing
advancement
use
defensive
peptides.
Improving
therapeutic
properties
these
strategy
reducing
clinical
limitations
synthetic
mimics
emerging
as
molecules
variety
applications.
These
be
made
significantly
shorter
while
maintaining,
or
even
improving
properties,
several
downsized
now
in
development
range
infectious
diseases.
A
strategies
employed
prepare
small
review
describes
different
developed
date
adhering
minimum
pharmacophore
based
an
amphiphilic
balance
between
cationic
charge
hydrophobicity.
dipeptides,
circumventing
need
large
elaborate
three-dimensional
structures
generate
simplified
potent
medical
This
highlight
key
recent
field
peptide
antimicrobials,
illustrating
just
how
you
go.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(11), С. 6108 - 6108
Опубликована: Май 29, 2022
In
the
last
few
years,
antibiotic
resistance
and,
analogously,
anticancer
drug
have
increased
considerably,
becoming
one
of
main
public
health
problems.
For
this
reason,
it
is
crucial
to
find
therapeutic
strategies
able
counteract
onset
multi-drug
(MDR).
review,
a
critical
overview
innovative
tools
available
today
fight
MDR
reported.
direction,
use
membrane-disruptive
peptides/peptidomimetics
(MDPs),
such
as
antimicrobial
peptides
(AMPs),
has
received
particular
attention,
due
their
high
selectivity
and
limited
side
effects.
Moreover,
similarities
between
bacteria
cancer
cells
are
herein
reported
hypothesis
possible
AMPs
also
in
therapies
discussed.
However,
important
take
into
account
limitations
that
could
negatively
impact
clinical
application
particular,
need
for
an
efficient
delivery
system.
regard,
nanoparticles
(NPs)
proposed
potential
strategy
improve
therapy;
moreover,
among
polymeric
NPs,
cationic
ones
emerging
promising
both
cells.
Computational and Structural Biotechnology Journal,
Год журнала:
2024,
Номер
23, С. 972 - 981
Опубликована: Фев. 12, 2024
Antimicrobial
peptides
(AMPs)
are
molecules
found
in
most
organisms,
playing
a
vital
role
innate
immune
defense
against
pathogens.
Their
mechanism
of
action
involves
the
disruption
bacterial
cell
membranes,
causing
leakage
cellular
contents
and
ultimately
leading
to
death.
While
AMPs
typically
lack
defined
structure
solution,
they
often
assume
conformation
when
interacting
with
membranes.
Given
this
structural
flexibility,
we
investigated
whether
intrinsically
disordered
regions
(IDRs)
AMP-like
properties
could
exhibit
antimicrobial
activity.
We
tested
14
from
different
IDRs
predicted
have
activity
that
nearly
all
them
did
not
display
anticipated
effects.
These
failed
adopt
secondary
had
compromised
membrane
interactions,
resulting
hypothesize
evolutionary
constraints
may
prevent
folding,
even
membrane-like
environments,
limiting
their
potential.
Moreover,
our
research
reveals
current
predictors
fail
accurately
capture
features
dealing
unstructured
sequences.
Hence,
results
presented
here
far-reaching
implications
for
designing
improving
strategies
therapies
infectious
diseases.